|
CR20220178A
(es)
|
2019-10-25 |
2022-06-15 |
Gilead Sciences Inc |
Compuestos moduladores de glp-1r
|
|
SI4097097T1
(sl)
|
2020-01-29 |
2025-04-30 |
Gilead Sciences, Inc. |
Spojine, ki modulirajo glp-1r
|
|
WO2021219019A1
(en)
|
2020-04-29 |
2021-11-04 |
Gasherbrum Bio, Inc. |
Heterocyclic glp-1 agonists
|
|
CN117645601A
(zh)
*
|
2020-06-10 |
2024-03-05 |
重庆康丁医药技术有限公司 |
一种具有心血管益处的glp-1小分子
|
|
PE20231181A1
(es)
|
2020-08-06 |
2023-08-11 |
Gasherbrum Bio Inc |
Agonistas del glp-1 heterociclicos
|
|
JP2023538949A
(ja)
|
2020-08-28 |
2023-09-12 |
ガシャーブラム・バイオ・インコーポレイテッド |
ヘテロ環ｇｌｐ－１アゴニスト
|
|
JP7812052B2
(ja)
|
2020-09-01 |
2026-02-09 |
江蘇恒瑞医薬股▲ふん▼有限公司 |
縮合イミダゾール誘導体、その調製方法及びその医薬的応用
|
|
EP4247804A1
(en)
|
2020-11-20 |
2023-09-27 |
Gilead Sciences, Inc. |
Polyheterocyclic glp-1 r modulating compounds
|
|
US20240252492A1
(en)
*
|
2021-01-28 |
2024-08-01 |
Carmot Therapeutics ,Inc. |
Gpcr receptor agonists, pharmaceutical compositions comprising the same, and methods for their use
|
|
WO2022184849A1
(en)
*
|
2021-03-04 |
2022-09-09 |
Les Laboratoires Servier |
Glp-1r agonists, uses and pharmaceutical compositions thereof
|
|
US12180197B2
(en)
|
2021-03-11 |
2024-12-31 |
Gilead Sciences, Inc. |
GLP-1R modulating compounds
|
|
EP4304711A1
(en)
|
2021-03-11 |
2024-01-17 |
Gilead Sciences, Inc. |
Glp-1r modulating compounds
|
|
CN116940561B
(zh)
*
|
2021-03-22 |
2026-08-11 |
杭州中美华东制药有限公司 |
噻吩类glp-1受体激动剂及其用途
|
|
EP4317145A4
(en)
*
|
2021-03-24 |
2025-03-12 |
Shionogi & Co., Ltd |
Pharmaceutical composition containing glp-1 receptor agonist having fused ring
|
|
US20220348564A1
(en)
*
|
2021-03-24 |
2022-11-03 |
Eccogene (Shanghai) Co., Ltd. |
Phenyl-[1,3]dioxolo[4,5-c]pyridinyl-phenyl-, phenyl-[1,3]dioxolo[4,5-c]pyridinyl-heteroaryl-, or phenyl-(1,3)dioxo[4,5-c]pyridinyl-piperidinyl-methyl-oxetanylmethyl-1h-benzo[d]imidazole-carboxylic acid derivatives and methods of using same
|
|
LT4271672T
(lt)
|
2021-04-21 |
2026-03-10 |
Gilead Sciences, Inc. |
Karboksibenzimidazolo junginiai, moduliuojantys glp-1r
|
|
TWI843104B
(zh)
|
2021-05-20 |
2024-05-21 |
美商美國禮來大藥廠 |
類升糖素肽1受體促效劑
|
|
US20240360109A1
(en)
*
|
2021-08-04 |
2024-10-31 |
Shanghai Hansoh Biomedical Co., Ltd. |
Cycloalkene derivative regulator, preparation method therefor, and application thereof
|
|
KR20240056719A
(ko)
|
2021-09-08 |
2024-04-30 |
시오노기 앤드 컴파니, 리미티드 |
항비만 작용이 관여하는 질환의 예방 및 치료용 의약
|
|
SI4408840T1
(sl)
|
2021-09-27 |
2025-12-31 |
Terns Pharmaceuticals, Inc. |
Benzimidazolne karboksilne kisline kot agonisti GLP-1R
|
|
US20250236627A1
(en)
|
2021-10-05 |
2025-07-24 |
Astrazeneca Ab |
Certain octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
WO2023057427A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes as glp-1 receptor modulators
|
|
WO2023057429A1
(en)
|
2021-10-05 |
2023-04-13 |
Astrazeneca Ab |
Certain 2,5-diazabicyclo[4.2.0]octanes and octahydrofuro[3,4- b]pyrazines as glp-1 receptor modulators
|
|
US12024507B2
(en)
|
2021-10-25 |
2024-07-02 |
Terns Pharmaceuticals, Inc. |
Compounds as GLP-1R agonists
|
|
US20250066338A1
(en)
|
2021-12-16 |
2025-02-27 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
US20250042882A1
(en)
|
2021-12-16 |
2025-02-06 |
Astrazeneca Ab |
Certain 3-azabicyclo[3.1.0]hexanes as glp-1 receptor modulators
|
|
AU2023224854A1
(en)
*
|
2022-02-23 |
2024-10-03 |
Terns Pharmaceuticals, Inc. |
Compounds as glp-1r agonists
|
|
CA3246495A1
(en)
*
|
2022-03-25 |
2023-09-28 |
Ildong Pharmaceutical Co., Ltd. |
NEW GLP-1 RECEPTOR AGONIST COMPOUND SALT, ITS PREPARATION PROCESS AND PHARMACEUTICAL COMPOSITION INCLUDING IT
|
|
CN116574092B
(zh)
*
|
2022-05-20 |
2024-08-20 |
成都地奥九泓制药厂 |
苯并咪唑或氮杂苯并咪唑类化合物、其制备方法及其应用
|
|
CN120289449A
(zh)
*
|
2022-07-18 |
2025-07-11 |
厦门市博瑞来医药科技有限公司 |
一种合成非甾体类fxr调节剂的化合物
|
|
CN119907794A
(zh)
|
2022-09-22 |
2025-04-29 |
盐野义制药株式会社 |
具有glp-1受体激动剂作用的稠环化合物
|
|
US20260098031A1
(en)
*
|
2022-09-22 |
2026-04-09 |
Shionogi & Co., Ltd. |
Monocyclic compound having glp-1 receptor agonist activity
|
|
CN116102543B
(zh)
*
|
2022-10-21 |
2025-07-22 |
江南大学 |
一种glp-1r激动剂、合成方法及其用途
|
|
WO2024102625A1
(en)
|
2022-11-11 |
2024-05-16 |
Eli Lilly And Company |
Glucagon-like peptide 1 receptor agonists
|
|
CR20250178A
(es)
|
2022-11-16 |
2025-06-06 |
Lilly Co Eli |
Agonistas del receptor del péptido-1 similar al glucagón
|
|
KR20250139383A
(ko)
*
|
2023-02-02 |
2025-09-23 |
장쑤 한서 파마슈티칼 그룹 캄파니 리미티드 |
시클로알켄계 화합물의 염, 결정형 및 이의 제조 방법과 응용
|
|
PE20252787A1
(es)
|
2023-04-07 |
2025-12-22 |
Terns Pharmaceuticals Inc |
Combinacion que comprende un agonista de thr-beta y un agonista de glp-1r para su uso en el tratamiento de un trastorno hepatico o una enfermedad cardiometabolica
|
|
WO2024212742A1
(zh)
*
|
2023-04-10 |
2024-10-17 |
上海研健新药研发有限公司 |
一种glp-1r激动剂，其制备方法和应用
|
|
EP4777197A2
(en)
|
2023-09-14 |
2026-07-22 |
Ascletis Pharma (China) Co., Limited |
Glp-1r agonist and therapeutic method thereof
|
|
EP4780818A1
(en)
*
|
2023-09-21 |
2026-07-29 |
Yunovia Co., Ltd. |
Method for preparing substituted fused imidazole derivative
|
|
WO2025109387A1
(en)
|
2023-11-24 |
2025-05-30 |
Ascletis Pharma (China) Co., Limited |
Glp-1r agonist and therapeutic method thereof
|
|
TW202600132A
(zh)
|
2024-03-08 |
2026-01-01 |
美商安尼波那生物公司 |
用於治療肥胖症及提高減重之方法
|
|
WO2026092580A1
(en)
|
2024-10-30 |
2026-05-07 |
Ascletis Pharma (China) Co., Limited |
Glp-1r\gipr\gcgr modulator in combination with thr-beta modulator for treatment of metabolic diseases
|
|
WO2026092581A1
(en)
|
2024-10-30 |
2026-05-07 |
Ascletis Pharma (China) Co., Limited |
Thyroid hormone receptor beta modulator alone or in combination with a modulator of glp-1r, gipr or gcgr, for use in the treatment of obesity or overweight or for treating alopecia areata
|
|
WO2026092583A1
(en)
|
2024-10-30 |
2026-05-07 |
Ascletis Pharma (China) Co., Limited |
Thr-beta modulators, alone or in combination with glp-1r\gipr\gcgr modulators for the treatment of metabolic diseases and alopecia areata diseases
|
|
WO2026151251A1
(ko)
*
|
2025-01-10 |
2026-07-16 |
유노비아 주식회사 |
Glp-1r 작용제를 포함하는 대사성 질환 예방 또는 치료용 조성물
|